What's New

With this version of MDALL we introduced the new Common Look and Feel version 2 standards enabling the display of more information on the screen and a more intuitive user interface.

The application was also enhanced to display the "Licence Type" information associated with every product. This information is located on the same line as the licence number on the right hand side of the screen.

In addition the MDALL has been updated to display Summary Basis of Decision (SBD), Notice of Decision (ND) and Operator's Manual and/or Package Insert documents. For licences with a SBD review a new column called "Additional Information" will be displayed beside the licence name. The detailed information can be accessed by clicking on the hyperlink associated to the document you would like to view.

Note: The SBD project was developed in response to Health Canada's commitment to enhance the transparency of the drug and medical device regulatory review processes. The SBD documents linked to the MDALL database outline the scientific and benefit/risk based decisions that factor into Health Canada's decision to grant market authorization for a device. The documents include regulatory, safety, efficacy and quality (chemistry and manufacturing) considerations. Not all licences will be accompanied by these documents as the Summary Basis of Decision project is being implemented in a phased approach, beginning with a subset of Class IV devices licensed subsequent to January 1, 2005.